Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1075962]Researchers: A/Pr Mark Smythe (Principal investigator) , A/Pr Simon Phipps
Brief description Prostaglandin D2 (PGD2) is a key driver of asthma and allergic rhinitis. We have developed drug-like compounds that block the synthesis of PGD2 by inhibiting the hematopoietic prostaglandin D2 synthase (HPGD2S) enzyme. This project aims to develop these compounds further to ultimately treat a subset of the asthma population that are not well treated, refractory asthmatics.
Funding Amount $AUD 338,321.70
Funding Scheme Development Grants
Notes Development Grant
- nhmrc : 1075962
- PURL : https://purl.org/au-research/grants/nhmrc/1075962
